Status:
COMPLETED
Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Covid19
Follow up
Eligibility:
All Genders
18+ years
Brief Summary
Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Subject male or female ≥ 18 years old
- Patient hospitalized in the anesthesia-resuscitation department of the NHC for COVID-19 from March 1, 2020.
- Patient (or his legal representative) having given his consent for the use of his data for the purposes of this research.
- exclusion criteria:
- Subject not hospitalized in intensive care
- Patient's refusal to participate in the study
- Inability to give informed information to the subject (subject in an emergency, difficulty understanding the subject, etc.)
- Subject under low protection
Exclusion
Key Trial Info
Start Date :
July 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 21 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04491214
Start Date
July 24 2020
End Date
January 21 2021
Last Update
February 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Strasbourg (Nouvel Hôpital Civil)
Strasbourg, France, 67117